Novartis Investigative Site

Coswig 01640

0 studies enrolling now · 3 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Non-Small Cell Lung Cancer

Studies at this site

• To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF — Stopped early
• Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early